Epigenomics' Q1 Revenues Increase 46 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – German molecular diagnostics company Epigenomics reported today that its first-quarter revenues increased 46 percent year over year.

For the three months ended March 31, total revenues were €355,000 ($468,000), up from €243,000 in the first quarter a year ago.

Its product sales increased to €163,000 from €125,000 a year ago, while R&D service income shot up to €126,000 from €4,000. Licensing revenues were down to €66,000 from €114,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."